149 related articles for article (PubMed ID: 10522270)
21. Synthesis, structure elucidation and identification of antitumoural properties of novel fused 1,2,4-triazine aryl derivatives.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M
Eur J Med Chem; 2008 May; 43(5):1085-94. PubMed ID: 17868955
[TBL] [Abstract][Full Text] [Related]
22. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():328-375. PubMed ID: 28851503
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and cytotoxic activity of imidazo[1,2-a]-1,3,5-triazine analogues of 6-mercaptopurine.
Saczewski F; Maruszak M; Bednarski PJ
Arch Pharm (Weinheim); 2008 Feb; 341(2):121-5. PubMed ID: 18186543
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and bioactivity of 4,10-dimethyl-pyridino[2,3-h]quinolin-2(1H)-one-9-carboxylic acid and its esters.
Zhang Q; Chen Y; Zheng YQ; Xia P; Xia Y; Yang ZY; Bastow KF; Morris-Natschke SL; Lee KH
Bioorg Med Chem; 2003 Mar; 11(6):1031-4. PubMed ID: 12614889
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.
Mahajan DH; Pannecouque C; De Clercq E; Chikhalia KH
Arch Pharm (Weinheim); 2009 May; 342(5):281-90. PubMed ID: 19415671
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antitumor activity of benzimidazolyl-1,3,5-triazine and benzimidazolylpyrimidine derivatives.
Matsuno T; Karo M; Sasahara H; Watanabe T; Inaba M; Takahashi M; Yaguchi SI; Yoshioka K; Sakato M; Kawashima S
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1778-81. PubMed ID: 11086914
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structure elucidation and in vitro anticancer activities of novel derivatives of diethyl (2E)-2-[(2E)-(1-arylimidazolidin-2-ylidene)hydrazono]succinate and ethyl (4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)acetate.
Sztanke M; Rzymowska J; Sztanke K
Bioorg Med Chem; 2013 Dec; 21(23):7465-80. PubMed ID: 24126095
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, structural characterization and antitumor activity of novel 2,4-diamino-1,3,5-triazine derivatives.
Brzozowski Z; Saczewski F; Gdaniec M
Eur J Med Chem; 2000 Dec; 35(12):1053-64. PubMed ID: 11248404
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, crystal structure and anticancer activity of novel derivatives of ethyl 1-(4-oxo-8-aryl-4,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3-yl)formate.
Sztanke K; Rzymowska J; Niemczyk M; Dybała I; Kozioł AE
Eur J Med Chem; 2006 Apr; 41(4):539-47. PubMed ID: 16545495
[TBL] [Abstract][Full Text] [Related]
30. Derivatives of 2-mercaptobenzenesulphonamide. XIX. Syntheses, anticancer and anti-HIV activities of some 2-(4-chloro-2-mercaptobenzenesulphonylimino) perhydropyrimidines.
Pomarnacka E
Acta Pol Pharm; 1996; 53(5):373-8. PubMed ID: 9415213
[TBL] [Abstract][Full Text] [Related]
31. Identification of antitumour activity of novel derivatives of 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione and 8-aryl-4-imino-2,3,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazin-3(6H)-one.
Sztanke K; Pasternak K; Rzymowska J; Sztanke M; Kandefer-Szerszeń M; Dybała I; Kozioł AE
Bioorg Med Chem; 2007 Apr; 15(8):2837-49. PubMed ID: 17331732
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of novel thiazolo[4,5-d]pyrimidine derivatives for antimicrobial, anti-HIV and anticancer investigation.
Rida SM; Habib NS; Badawey EA; Fahmy HT; Ghozlan HA
Pharmazie; 1996 Dec; 51(12):927-31. PubMed ID: 8985982
[TBL] [Abstract][Full Text] [Related]
33. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain.
Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2009 Apr; 6(4):561-8. PubMed ID: 19353537
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of a series of Homopterocarpane derivatives with potential antitumor and anti-AIDS activity.
Valenti P; Fabbri G; Rampa A; Bisi A; Belluti F
Farmaco; 1997 Jan; 52(1):13-9. PubMed ID: 9181675
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, antimicrobial activity and anti-HIV activity evaluation of novel hybrid quinazoline-triazine derivatives.
Modh RP; De Clercq E; Pannecouque C; Chikhalia KH
J Enzyme Inhib Med Chem; 2014 Feb; 29(1):100-8. PubMed ID: 23327639
[TBL] [Abstract][Full Text] [Related]
36. 1,3,5-Triazines: A promising scaffold for anticancer drugs development.
Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G
Eur J Med Chem; 2017 Dec; 142():523-549. PubMed ID: 29046238
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of new derivatives of 2,3-dihydro-7-benzo[b]furanol with potential pharmacological activity.
Kossakowski J; Ostrowska K
Acta Pol Pharm; 2006; 63(4):271-5. PubMed ID: 17203863
[TBL] [Abstract][Full Text] [Related]
38. Convenient synthesis of fused heterocyclic 1,3,5-triazines from some N-acyl imidates and heterocyclic amines as anticancer and antioxidant agents.
Bekircan O; Küxük M; Kahveci B; Kolayli S
Arch Pharm (Weinheim); 2005 Aug; 338(8):365-72. PubMed ID: 16041836
[TBL] [Abstract][Full Text] [Related]
39. Triazine as a promising scaffold for its versatile biological behavior.
Singla P; Luxami V; Paul K
Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives.
Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H
Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]